Birgit Koenigs
CFO
Replay available
Sonova Holding AG (LSE: 0QPY) Q2 2025 earnings conference call, held 2024-11-19. Replay captured from the company's public earnings webcast.

CFO
Analyst at Deutsche Bank
Analyst at ODDO
Analyst at BNP Paribas
Analyst at Barclays
Analyst at JPMorgan
Analyst at Morgan Stanley
Analyst at Kepler-Ferrer
Analyst at Citi
Analyst at Research Partners
Analyst at Bank of America
Analyst at UBS
CEO
Ladies and gentlemen, welcome to the Sonova Holding AG half-year results 2024-2025 conference call and live webcast. I'm Sandra, the chorus call operator. I would like to remind you that all participants have been listened only mode and the conference has been recorded. The presentation will be followed by a Q&A session. You can register for questions at any time by pressing star and one on your telephone. For operator assistance, please press star and zero. The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Arne Kaldowski, CEO. Please go ahead, sir. Sandra, thank you. A warm welcome to everybody on the call to our half-year results 2024-25. I have next to me Birgit Koenigs, our CFO, and Thomas Berners-Kotter, our Senior Director for Industrial Relations. We want to, at the beginning, share the half-year results with over a little bit the slides you have in front of you, talk a little bit about market trend, and I am sure a well-received update on the progress we're making with Infineo and Sphere after the launch in August and September. On the disclaimer, please take note the presentation contains forward-looking statements. Everything else is well-known, so please look at it that way. Looking at the summary for the first half year, I think on a high level, we have been able to realize solid sales growth, driven by share gains in hearing instruments and cochlear implants. On the hearing instrument side, despite us being in a late cycle until we launched Infineon Sphere, Also strong development in the cochlear implant side, picking up momentum relative to the year before. We have some challenging market conditions and also headwinds from lead generation in the audiological care side, and particularly the m...